{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:46:14Z","timestamp":1793915174154,"version":"4.8.0"},"reference-count":144,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2025,9,21]]},"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:p>The primary aims of this best practice article are to provide a laboratory perspective of the merits and pitfalls of different markers currently in use in UK National Health Service (NHS) hospital laboratories, and how best these tests can be used for the detection of heavy (harmful) alcohol consumption. Included are suggested testing algorithms for carbohydrate-deficient transferrin (CDT), ethyl glucuronide (EtG), ethyl sulphate (EtS) and phosphatidylethanol (PEth16:0\/18:1), for the purpose of creating suitable bench-to-bedside alcohol services in support of the delivery of hospital alcohol strategy, and the NHS long-term health plan.<\/jats:p>","DOI":"10.1136\/jcp-2024-210001","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:20:34Z","timestamp":1760548834000},"page":"161-168","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Laboratory requirements for assessment of alcohol misuse"],"prefix":"10.1136","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-2129-871X","authenticated-orcid":false,"given":"Loretta","family":"Ford","sequence":"first","affiliation":[{"name":"Black Country Pathology Services, Wolverhampton, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"2026021902550842000_79.3.161.1","unstructured":"NHS England . Health survey for England, 2022 part 1. 2024. Available: https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/health-survey-for-england\/2022-part-1\/adult-drinking [Accessed 24 Jan 2025]."},{"key":"2026021902550842000_79.3.161.2","unstructured":"The scottish government . Scottish health survey 2022 edition. 2022. Available: https:\/\/www.gov.scot\/binaries\/content\/documents\/govscot\/publications\/statistics\/2023\/12\/scottish-health-survey-2022-volume-1-main-report\/documents\/scottish-health-survey-2022-main-report\/scottish-health-survey-2022-main-report\/govscot%3Adocument\/scottish-health-survey-2022-main-report.pdf. (accessed 24 Jan 2025)"},{"key":"2026021902550842000_79.3.161.3","unstructured":"Welsh Government . National survey for wales headline results: april 2022 to march 2023. 2023. Available: https:\/\/www.gov.wales\/national-survey-wales-headline-results-april-2022-march-2023-html [Accessed 24 Jan 2025]."},{"key":"2026021902550842000_79.3.161.4","unstructured":"Information analysis directorate . Health survey (NI) first results 2022\/023. 2023. Available: https:\/\/www.drugsandalcohol.ie\/40042\/1\/hsni-first-results-22-23.pdf [Accessed 24 Jan 2025]."},{"key":"2026021902550842000_79.3.161.5","unstructured":"Department of Health . UK chief medical officers\u2019 low risk drinking guidelines. 2016. Available: https:\/\/assets.publishing.service.gov.uk\/media\/5a80b7ed40f0b623026951db\/UK_CMOs__report.pdf"},{"key":"2026021902550842000_79.3.161.6","doi-asserted-by":"publisher","DOI":"10.1111\/add.14642"},{"key":"2026021902550842000_79.3.161.7","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/fdr033"},{"key":"2026021902550842000_79.3.161.8","unstructured":"House of commons library . Gross domestic product (GDP): economic indicators. 2025. Available: https:\/\/researchbriefings.files.parliament.uk\/documents\/SN02783\/SN02783.pdf"},{"key":"2026021902550842000_79.3.161.9","unstructured":"Public Health England . The public health burden of alcohol and the effectiveness and cost-effectiveness of alcohol control policies an evidence review. 2016. Available: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/733108\/alcohol_public_health_burden_evidence_review_update_2018"},{"key":"2026021902550842000_79.3.161.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32420-5"},{"key":"2026021902550842000_79.3.161.11","unstructured":"World Health Organization . The icd-10 classification of mental and behavioural disorders: diagnostic criteria for research. Geneva: World Health Organization; 2004. Available: https:\/\/iris.who.int\/bitstream\/handle\/10665\/37958\/9241544228_eng.pdf"},{"key":"2026021902550842000_79.3.161.12","unstructured":"Babor TF , Higgins-Biddle JC , Saunders JB , et al . AUDIT: the alcohol use disorders identification test. guidelines for use in primary health care. 2001. Available: https:\/\/iris.who.int\/bitstream\/handle\/10665\/67205\/WHO_MSD_MSB_01.6a.pdf;jsessionid=F1FF067AB77786B703AD043818D567EF?sequence=1"},{"key":"2026021902550842000_79.3.161.13","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/alcalc\/agx094","article-title":"Effectiveness of Mass Media Campaigns to Reduce Alcohol Consumption and Harm: A Systematic Review","volume":"53","author":"Young","year":"2018","journal-title":"Alcohol Alcohol"},{"key":"2026021902550842000_79.3.161.14","unstructured":"Office for National Statistic . Alcohol specific deaths in uk registered in 2023. 2025. Available: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/healthandsocialcare\/causesofdeath\/bulletins\/alcoholrelateddeathsintheunitedkingdom\/registeredin2023 [Accessed 20 Feb 2025]."},{"key":"2026021902550842000_79.3.161.15","unstructured":"World health organisation International agency for research on cancer . IARC Monographs on the evaluation of carcinogenic risks to humans. Alcohol drinking.1988. Available: https:\/\/publications.iarc.fr\/Book-And-Report-Series\/Iarc-Monographs-On-The-Identification-Of-Carcinogenic-Hazards-To-Humans\/Alcohol-Drinking-1988"},{"key":"2026021902550842000_79.3.161.16","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0029-6"},{"key":"2026021902550842000_79.3.161.17","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.579"},{"key":"2026021902550842000_79.3.161.18","unstructured":"NHS Blood and Transport . Annual report on liver transplantation report for 2022\/2023 (1 april 2013 \u2013 31 march 2023). 2023. Available: https:\/\/nhsbtdbe.blob.core.windows.net\/umbraco-assets-corp\/30875\/nhsbt-liver-transplantation-report-2223.pdf"},{"key":"2026021902550842000_79.3.161.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61838-9"},{"key":"2026021902550842000_79.3.161.20","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S2468-1253(21)00195-3","article-title":"Liver transplantation for alcohol-related liver disease in the UK: revised UK Liver Advisory Group recommendations for referral","volume":"6","author":"Masson","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026021902550842000_79.3.161.21","unstructured":"Home office for improvement & disparities . Liver disease profile april 2024 update. 2024. Available: https:\/\/www.gov.uk\/government\/statistics\/liver-disease-profile-april-2024-update\/liver-disease-profile-april-2024-update [Accessed 24 Feb 2025]."},{"key":"2026021902550842000_79.3.161.22","doi-asserted-by":"crossref","first-page":"e290","DOI":"10.1016\/S2214-109X(17)30021-9","article-title":"Estimation of national, regional, and global prevalence of alcohol use during pregnancy and fetal alcohol syndrome: a systematic review and meta-analysis","volume":"5","author":"Popova","year":"2017","journal-title":"Lancet Glob Health"},{"key":"2026021902550842000_79.3.161.23","unstructured":"Department of health and social care . Guidance: fetal alcohol spectrim disorder: health needs assessment. 2021. Available: https:\/\/www.gov.uk\/government\/publications\/fetal-alcohol-spectrum-disorder-health-needs-assessment\/fetal-alcohol-spectrum-disorder-health-needs-assessment [Accessed 24 Feb 2025]."},{"key":"2026021902550842000_79.3.161.24","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2020-320435"},{"key":"2026021902550842000_79.3.161.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2018.10.013"},{"key":"2026021902550842000_79.3.161.26","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1111\/acer.14705","article-title":"Prevalence of fetal alcohol spectrum disorder in Greater Manchester, UK: An active case ascertainment study","volume":"45","author":"McCarthy","year":"2021","journal-title":"Alcohol Clin Exp Res"},{"key":"2026021902550842000_79.3.161.27","unstructured":"National Organisation for FASD . New study: fasd affects millions in the UK. 2021. Available: https:\/\/nationalfasd.org.uk\/new-study-shows-fasd-affects-millions-in-the-uk-2021\/ [Accessed 26 Feb 2025]."},{"key":"2026021902550842000_79.3.161.28","unstructured":"Royal College of Physcians . Alcohol - can the nhs afford it? recommendations for a coherent alcohol strategy for hospitals royal college of physicians. 2001. Available: https:\/\/shop.rcp.ac.uk\/products\/alcohol-can-the-nhs-afford-it-recommendations-for-a-coherent-alcohol-strategy-for-hospitals?variant=6298853637 [Accessed 26 Feb 2025]."},{"key":"2026021902550842000_79.3.161.29","doi-asserted-by":"crossref","unstructured":"HM Government . The governments alcohol strategy. 2012. Available: https:\/\/assets.publishing.service.gov.uk\/media\/5a755606ed915d7314959292\/alcohol-strategy.pdf","DOI":"10.1108\/add.2012.54105baa.002"},{"key":"2026021902550842000_79.3.161.30","unstructured":"Public Health England . Alcohol care in england\u2019s hospitals an opportunity not to be wasted. 2014. Available: https:\/\/ranzetta.typepad.com\/files\/alcohol_care_in_englands_hospitals-phe-2014.pdf"},{"key":"2026021902550842000_79.3.161.31","unstructured":"NHS long term plan. 2019. Available: https:\/\/www.longtermplan.nhs.uk\/wp-content\/uploads\/2019\/08\/nhs-long-term-plan-version-1.2.pdf"},{"key":"2026021902550842000_79.3.161.32","unstructured":"Public Health England . Alcohol care teams: core service descriptor. 2019. Available: https:\/\/www.longtermplan.nhs.uk\/wp-content\/uploa ds\/2019\/11\/ACT-core-service-descriptor-051119.pdf"},{"key":"2026021902550842000_79.3.161.33","unstructured":"Home office for improvement & disparities . Closed consultation. UK clinical guidelines for alcohol treatment: core elements of alcohol treatment. 2023. Available: https:\/\/www.gov.uk\/government\/consultations\/uk-clinical-guidelines-for-alcohol-treatment\/uk-clinical-guidelines-for-alcohol-treatment-core-elements-of-alcohol-treatment [Accessed 26 Feb 2025]."},{"key":"2026021902550842000_79.3.161.34","unstructured":"National institute for health and care excellence (NICE) . Alcohol-use disorders: diagnosis, assessment and management of harmful drinking (high-risk drinking) and alcohol dependence: clinical guideline (nice guideline, no.115.). 2014."},{"key":"2026021902550842000_79.3.161.35","unstructured":"World health organization . Audit: the alcohol use disorders identification test\u2014guidelines for use in primary care; world health organization, department of mental health and substance dependence. Geneva, Switzerland, 2001. Available: https:\/\/iris.who.int\/bitstream\/handle\/10665\/67205\/WHO_MSD_MSB_01.6a-eng.pdf?sequence=1"},{"key":"2026021902550842000_79.3.161.36","doi-asserted-by":"publisher","DOI":"10.1002\/lt.21163"},{"key":"2026021902550842000_79.3.161.37","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18179266","article-title":"Validation of the AUDIT and AUDIT-C for Hazardous Drinking in Community-Dwelling Older Adults","volume":"18","author":"van Gils","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"2026021902550842000_79.3.161.38","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12302"},{"key":"2026021902550842000_79.3.161.39","unstructured":"Lewis T , Wood M , Myers M . Pathology grift programme national speciality report. 2021. Available: https:\/\/www.gettingitrightfirsttime.co.uk\/wp-content\/uploads\/2022\/05\/Pathology-4May22j.pdf"},{"key":"2026021902550842000_79.3.161.40","doi-asserted-by":"crossref","unstructured":"Thomas SN , French D , Jannetto PJ , et al . Liquid chromatography\u2013tandem mass spectrometry for clinical diagnostics. Nat Rev Methods Primers 2002;2. doi:10.1038\/s43586-022-00175-x","DOI":"10.1038\/s43586-022-00175-x"},{"key":"2026021902550842000_79.3.161.41","unstructured":"Croal B . The Royal College of Pathologists. The communication of critical and unexpected pathology results, 2017. Available: https:\/\/www.rcpath.org\/static\/bb86b370-1545-4c5a-b5826a2c431934f5\/The-communication-of-critical-and-unexpected-pathology-results.pdf"},{"key":"2026021902550842000_79.3.161.42","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/19.3.192"},{"key":"2026021902550842000_79.3.161.43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5897\/JCPFM12.003","article-title":"Is there a role for ethanol assay using alcohol dehydrogenase in a basic drugs and alcohol screen of blood following routine autopsies?","volume":"3","author":"Tormey","year":"2012","journal-title":"J Clin Pathol Forensic Med"},{"key":"2026021902550842000_79.3.161.44","doi-asserted-by":"crossref","DOI":"10.11613\/BM.2021.010704","article-title":"Effect of haemolysis on an enzymatic measurement of ethanol","volume":"31","author":"\u00c7at","year":"2021","journal-title":"Biochem Med (Zagreb)"},{"key":"2026021902550842000_79.3.161.45","doi-asserted-by":"crossref","first-page":"57","DOI":"10.11613\/BM.2015.006","article-title":"Comparison of blood ethanol stabilities in different storage periods","volume":"25","author":"Emel Kocak","year":"2015","journal-title":"Biochem Med"},{"key":"2026021902550842000_79.3.161.46","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/jat\/bkad013","article-title":"Preanalytical Factors Influencing the Stability of Ethanol in Antemortem Blood and Urine Samples","volume":"47","author":"Olds","year":"2023","journal-title":"J Anal Toxicol"},{"key":"2026021902550842000_79.3.161.47","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1520\/JFS13552J","article-title":"Production of Urinary Ethanol After Sample Collection","volume":"38","author":"Saady","year":"1993","journal-title":"Forensic Sci"},{"key":"2026021902550842000_79.3.161.48","first-page":"276","article-title":"A Positive Urine Alcohol with Negative Urine Ethyl-Glucuronide","volume":"49","author":"Foley","year":"2018","journal-title":"Lab Med"},{"key":"2026021902550842000_79.3.161.49","first-page":"157","article-title":"Blood alcohol analysis: a comparison of the gas-chromatographic assay with an enzymatic assay","volume":"16","author":"Taylor","year":"1984","journal-title":"Pathology (Phila)"},{"key":"2026021902550842000_79.3.161.50","doi-asserted-by":"publisher","DOI":"10.1373\/49.3.357"},{"key":"2026021902550842000_79.3.161.51","doi-asserted-by":"crossref","unstructured":"Krasowski MD , Wilcoxon RM , Miron J . A retrospective analysis of glycol and toxic alcohol ingestion: utility of anion and osmolal gaps. BMC Clin Pathol 2012;12. doi:10.1186\/1472-6890-12-1","DOI":"10.1186\/1472-6890-12-1"},{"key":"2026021902550842000_79.3.161.52","unstructured":"GOV.UK . The drink drive limit. Available: https:\/\/www.gov.uk\/drink-drive-limit [Accessed 1 Mar 2025]."},{"key":"2026021902550842000_79.3.161.53","first-page":"5","article-title":"Pharmacokinetic aspects of ethanol for medicolegal purposes","volume":"12","author":"Wu","year":"1991","journal-title":"Am Assoc Clin Chem Briefing"},{"key":"2026021902550842000_79.3.161.54","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.3.5569.819"},{"key":"2026021902550842000_79.3.161.55","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s40429-021-00402-7","article-title":"Blood Biomarkers of Alcohol Use: A Scoping Review","volume":"8","author":"Harris","year":"2021","journal-title":"Curr Addict Rep"},{"key":"2026021902550842000_79.3.161.56","doi-asserted-by":"publisher","DOI":"10.1016\/j.cll.2012.06.003"},{"key":"2026021902550842000_79.3.161.57","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0140-6736(78)90261-1","article-title":"BIOCHEMICAL AND HqMATOLOGICAL MARKERS OF ALCOHOL INTAKE","volume":"311","author":"Whitehead","year":"1978","journal-title":"The Lancet"},{"key":"2026021902550842000_79.3.161.58","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/cld.571","article-title":"Biomarkers for monitoring alcohol use","volume":"8","author":"Cabezas","year":"2016","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"2026021902550842000_79.3.161.59","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12062124"},{"key":"2026021902550842000_79.3.161.60","unstructured":"Ogun AS , Adeyinka A . StatPearls. Biochemistry, Transferrin.2025. Available: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK532928\/"},{"key":"2026021902550842000_79.3.161.61","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/clinchem\/37.12.2029","article-title":"Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed","volume":"37","author":"Stibler","year":"1991","journal-title":"Clin Chem"},{"key":"2026021902550842000_79.3.161.62","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1471-230X-14-97","article-title":"Diagnostic sensitivity of carbohydrate deficient transferrin in heavy drinkers","volume":"14","author":"Fagan","year":"2014","journal-title":"BMC Gastroenterol"},{"key":"2026021902550842000_79.3.161.63","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/CBF.S37239","article-title":"Biomarkers of chronic alcohol misuse","volume":"4","author":"Gonzalo","year":"2014","journal-title":"CBF"},{"key":"2026021902550842000_79.3.161.64","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2002.tb02658.x"},{"key":"2026021902550842000_79.3.161.65","doi-asserted-by":"crossref","first-page":"914","DOI":"10.3390\/toxics11110914","article-title":"Carbohydrate-Deficient Transferrin (CDT) as a Biomarker of Alcohol Abuse: A Retrospective Study of the Italian Drinking Trend among Drivers from 2016 to 2022","volume":"11","author":"Fiorelli","year":"2023","journal-title":"Toxics"},{"key":"2026021902550842000_79.3.161.66","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jpba.2017.09.006","article-title":"Analytical and diagnostic aspects of carbohydrate deficient transferrin (CDT): A critical review over years 2007\u20132017","volume":"147","author":"Bortolotti","year":"2018","journal-title":"J Pharm Biomed Anal"},{"key":"2026021902550842000_79.3.161.67","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/clinchem\/47.1.13","article-title":"Carbohydrate-deficient transferrin as a marker of chronic alcohol abuse: a critical review of preanalysis, analysis, and interpretation","volume":"47","author":"Arndt","year":"2001","journal-title":"Clin Chem"},{"key":"2026021902550842000_79.3.161.68","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2016.05.016"},{"key":"2026021902550842000_79.3.161.69","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cca.2016.12.022","article-title":"IFCC approved HPLC reference measurement procedure for the alcohol consumption biomarker carbohydrate-deficient transferrin (CDT): Its validation and use","volume":"465","author":"Schellenberg","year":"2017","journal-title":"Clin Chim Acta"},{"key":"2026021902550842000_79.3.161.70","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/36.5.406"},{"key":"2026021902550842000_79.3.161.71","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/jcla.21885","article-title":"Carbohydrate-Deficient Transferrin Determination in a Clinical Setting: Consistency Between Capillary Electrophoresis Assays and Utility of HPLC as a Confirmatory Test","volume":"30","author":"Veronesi","year":"2016","journal-title":"J Clin Lab Anal"},{"key":"2026021902550842000_79.3.161.72","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2006.12.028"},{"key":"2026021902550842000_79.3.161.73","unstructured":"Chromsystems (gr\u00e4felfing, germany) . CDT in serum with fast elution -hplc kit. Available: https:\/\/chromsystems.com\/en\/cdt-in-serum-with-fast-elution-hplc-54330-500 [Accessed 7 May 2025]."},{"key":"2026021902550842000_79.3.161.74","unstructured":"RECIPE ClinRep\u00ae (Munich, Germany) . HPLC complete kit for cdt in serum. Available: https:\/\/recipe.de\/products\/cdt-serum\/ [Accessed 7 May 2025]."},{"key":"2026021902550842000_79.3.161.75","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2001.150"},{"key":"2026021902550842000_79.3.161.76","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2008.03.033"},{"key":"2026021902550842000_79.3.161.77","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/agw069"},{"key":"2026021902550842000_79.3.161.78","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2003.029629"},{"key":"2026021902550842000_79.3.161.79","first-page":"BR61","article-title":"A prolonged time interval between blood sample collection and centrifugation causes an increase in serum carbohydrate-deficient transferrin","volume":"8","author":"Arndt","year":"2002","journal-title":"Med Sci Monit"},{"key":"2026021902550842000_79.3.161.80","doi-asserted-by":"publisher","DOI":"10.1006\/abio.2000.4717"},{"key":"2026021902550842000_79.3.161.81","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2003.023341"},{"key":"2026021902550842000_79.3.161.82","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.cca.2010.08.006","article-title":"Importance of HPLC confirmation of problematic carbohydrate-deficient transferrin (CDT) results from a multicapillary electrophoresis routine method","volume":"411","author":"Kenan","year":"2010","journal-title":"Clinica Chimica Acta"},{"key":"2026021902550842000_79.3.161.83","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2001.tb02182.x"},{"key":"2026021902550842000_79.3.161.84","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.3748\/wjg.v22.i14.3725","article-title":"Biomarkers for detection of alcohol consumption in liver transplantation","volume":"22","author":"Staufer","year":"2016","journal-title":"World J Gastroenterol"},{"key":"2026021902550842000_79.3.161.85","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cca.2020.04.014","article-title":"CDT reference values for monitoring chronic alcohol abuse in pregnancy","volume":"507","author":"Bortolotti","year":"2020","journal-title":"Clinica Chimica Acta"},{"key":"2026021902550842000_79.3.161.86","doi-asserted-by":"publisher","DOI":"10.1258\/acb.2011.011115"},{"key":"2026021902550842000_79.3.161.87","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/29.5.270"},{"key":"2026021902550842000_79.3.161.88","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.drugalcdep.2015.10.004","article-title":"Using ethyl glucuronide in urine to detect light and heavy drinking in alcohol dependent outpatients","volume":"157","author":"McDonell","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"2026021902550842000_79.3.161.89","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2010.01171.x"},{"key":"2026021902550842000_79.3.161.90","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/agn084"},{"key":"2026021902550842000_79.3.161.91","doi-asserted-by":"publisher","DOI":"10.1053\/j.semdp.2008.12.005"},{"key":"2026021902550842000_79.3.161.92","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2006.08.024"},{"key":"2026021902550842000_79.3.161.93","doi-asserted-by":"crossref","unstructured":"Simms P . B-161 liquid chromatography\/mass spectrometry analysis of ethyl glucuronide and ethyl sulfate using a perfluorophenyl stationary phase. 2024. Available: https:\/\/doi.org\/10.1093\/clinchem\/hvae106.521 [Accessed 24 Feb 2025].","DOI":"10.1093\/clinchem\/hvae106.521"},{"key":"2026021902550842000_79.3.161.94","unstructured":"Steimling J , Alagandula R , Carroll F . Successful strategies for the analysis of etg and ets in urine. technical note cfar3061a-unv. Available: https:\/\/www.restek.com\/fr\/documentation-technique\/articles\/successful-strategies-for-the-analysis-of-ETG-and-ETS-in-urine [Accessed 3 Mar 2025]."},{"key":"2026021902550842000_79.3.161.95","doi-asserted-by":"publisher","DOI":"10.1021\/ac060680+"},{"key":"2026021902550842000_79.3.161.96","doi-asserted-by":"crossref","unstructured":"Helander A , Kenan N , Beck O . Comparison of analytical approaches for liquid chromatography\/mass spectrometry determination of the alcohol biomarker ethyl glucuronide in urine RCM. 2010;24:1737\u201343.","DOI":"10.1002\/rcm.4573"},{"key":"2026021902550842000_79.3.161.97","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/26.5.262"},{"key":"2026021902550842000_79.3.161.98","unstructured":"Substance abuse and mental health services administration (samhsa) advisory (2012): the role of biomarkers in the treatment of alcohol use disorders. 2012. Available: https:\/\/www.niaaa.nih.gov\/sites\/default\/files\/SAMHSA-Advisory-Role-of-Biomarkers-in-the-Treatment-of-Alcohol-Use-Disorder-2012.pdf [Accessed 4 Mar 2025]."},{"key":"2026021902550842000_79.3.161.99","unstructured":"European guidelines for workplace drug testing in urine 2022-10 version 3.0. 2022. Available: https:\/\/www.ewdts.org\/wp-content\/uploads\/2022-10-ewdts-guidelines-urine-final.pdf [Accessed 15 Mar 2025]."},{"key":"2026021902550842000_79.3.161.100","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2012.01855.x"},{"key":"2026021902550842000_79.3.161.101","doi-asserted-by":"publisher","DOI":"10.1007\/s00414-012-0725-3"},{"key":"2026021902550842000_79.3.161.102","doi-asserted-by":"publisher","DOI":"10.1111\/acer.12699"},{"key":"2026021902550842000_79.3.161.103","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2005.051565"},{"key":"2026021902550842000_79.3.161.104","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1515\/cclm-2019-1302","article-title":"Challenges of LC-MS\/MS ethyl glucuronide analysis in abstinence monitoring of liver transplant candidates","volume":"58","author":"Heinemann","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"2026021902550842000_79.3.161.105","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2007.089482"},{"key":"2026021902550842000_79.3.161.106","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/34.2.84"},{"key":"2026021902550842000_79.3.161.107","doi-asserted-by":"publisher","DOI":"10.1093\/anatox\/35.2.85"},{"key":"2026021902550842000_79.3.161.108","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.drugalcdep.2015.12.011","article-title":"The effects of alcohol-containing e-cigarettes on young adult smokers","volume":"159","author":"Valentine","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"2026021902550842000_79.3.161.109","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2010.04.031"},{"key":"2026021902550842000_79.3.161.110","doi-asserted-by":"publisher","DOI":"10.1007\/s00414-010-0511-z"},{"key":"2026021902550842000_79.3.161.111","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2010.06.028"},{"key":"2026021902550842000_79.3.161.112","doi-asserted-by":"crossref","first-page":"S264","DOI":"10.1016\/S0168-8278(20)31031-X","article-title":"Prophylactic rifaximin use in liver transplant candidates is associated with false positive results of the alcohol biomarker, ethyl sulphate","volume":"73","author":"Webzell","year":"2020","journal-title":"J Hepatol"},{"key":"2026021902550842000_79.3.161.113","doi-asserted-by":"publisher","DOI":"10.1111\/acer.12407"},{"key":"2026021902550842000_79.3.161.114","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(83)80474-8"},{"key":"2026021902550842000_79.3.161.115","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/agl027"},{"key":"2026021902550842000_79.3.161.116","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1080\/00365513.2023.2253734","article-title":"The alcohol biomarker phosphatidylethanol (PEth) \u2013 test performance and experiences from routine analysis and external quality assessment","volume":"83","author":"Helander","year":"2023","journal-title":"Scand J Clin Lab Invest"},{"key":"2026021902550842000_79.3.161.117","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-010-3458-5"},{"key":"2026021902550842000_79.3.161.118","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2008.120923"},{"key":"2026021902550842000_79.3.161.119","first-page":"1747","article-title":"Nationell harmonisering av alkoholmark\u00f6ren PEth National harmonization of the alcohol biomarker PEth","volume":"110","author":"Helander","year":"2013","journal-title":"Lakartidningen"},{"key":"2026021902550842000_79.3.161.120","doi-asserted-by":"crossref","first-page":"12175","DOI":"10.3390\/ijms241512175","article-title":"Phosphatidylethanol (PEth) in Blood as a Marker of Unhealthy Alcohol Use: A Systematic Review with Novel Molecular Insights","volume":"24","author":"Perilli","year":"2023","journal-title":"IJMS"},{"key":"2026021902550842000_79.3.161.121","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/alcalc\/agad015","article-title":"Quantifying Alcohol Consumption in the General Population by Analysing Phosphatidylethanol Concentrations in Whole Blood: Results from 24,574 Subjects Included in the HUNT4 Study","volume":"58","author":"Skr\u00e5stad","year":"2023","journal-title":"Alcohol Alcohol"},{"key":"2026021902550842000_79.3.161.122","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/alcalc\/agz027","article-title":"Elimination Characteristics of the Alcohol Biomarker Phosphatidylethanol (PEth) in Blood during Alcohol Detoxification","volume":"54","author":"Helander","year":"2019","journal-title":"Alcohol Alcohol"},{"key":"2026021902550842000_79.3.161.123","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jaclp.2023.11.683","article-title":"Clinical Utility and Impact of Phosphatidylethanol Testing in Liver Transplantation Evaluations","volume":"65","author":"Fipps","year":"2024","journal-title":"J Acad Consult Liaison Psychiatry"},{"key":"2026021902550842000_79.3.161.124","doi-asserted-by":"crossref","DOI":"10.12659\/AOT.936293","article-title":"Phosphatidylethanol (PEth) for Monitoring Sobriety in Liver Transplant Candidates: Preliminary Results of Differences Between Alcohol-Related and Non-Alcohol-Related Cirrhosis Candidates","volume":"27","author":"Gundlach","year":"2022","journal-title":"Ann Transplant"},{"key":"2026021902550842000_79.3.161.125","article-title":"Phosphatidylethanol in Maternal or Neonatal Blood to Detect Alcohol Exposure during Pregnancy: A Systematic Review","volume":"12","author":"Franceschetto","year":"2022","journal-title":"Life (Basel)"},{"key":"2026021902550842000_79.3.161.126","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1111\/acer.15418","article-title":"Phosphatidylethanol is a promising tool for screening alcohol consumption during pregnancy","volume":"48","author":"H\u00e4kkinen","year":"2024","journal-title":"Alcohol, Clinical and Experimental Research"},{"key":"2026021902550842000_79.3.161.127","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/jat\/bkaa082","article-title":"Stability of Phosphatidylethanol 16:0\/18:1 in Freshly Drawn, Authentic Samples from Healthy Volunteers","volume":"45","author":"Skr\u00e5stad","year":"2021","journal-title":"J Anal Toxicol"},{"key":"2026021902550842000_79.3.161.128","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1007\/s00216-015-8565-x","article-title":"Effects of pre-analytical processes on blood samples used in metabolomics studies","volume":"407","author":"Yin","year":"2015","journal-title":"Anal Bioanal Chem"},{"key":"2026021902550842000_79.3.161.129","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/jat\/bkx075","article-title":"High Throughput UPLC\u00ae-MSMS Method for the Analysis of Phosphatidylethanol (PEth) 16:0\/18:1, a Specific Biomarker for Alcohol Consumption, in Whole Blood","volume":"42","author":"Andreassen","year":"2018","journal-title":"J Anal Toxicol"},{"key":"2026021902550842000_79.3.161.130","doi-asserted-by":"crossref","first-page":"464451","DOI":"10.1016\/j.chroma.2023.464451","article-title":"An accurate and precise liquid chromatography-tandem mass spectrometry method for the determination of six phosphatidylethanol homologues in whole blood with phospholipid interferences minimized","volume":"1711","author":"Maria","year":"2023","journal-title":"J Chromatogr A"},{"key":"2026021902550842000_79.3.161.131","unstructured":"World health organisation . International guide for monitoring alcohol consumption and related harm. 2002. Available: https:\/\/www.who.int\/publications\/i\/item\/international-guide-for-monitoring-alcohol-consumption-and-related-harm [Accessed 5 Mar 2025]."},{"key":"2026021902550842000_79.3.161.132","doi-asserted-by":"publisher","DOI":"10.1111\/1556-4029.13874"},{"key":"2026021902550842000_79.3.161.133","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1002\/dta.3340","article-title":"Consensus for the use of the alcohol biomarker phosphatidylethanol (PEth) for the assessment of abstinence and alcohol consumption in clinical and forensic practice (2022 Consensus of Basel)","volume":"14","author":"Luginb\u00fchl","year":"2022","journal-title":"Drug Test Anal"},{"key":"2026021902550842000_79.3.161.134","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/jat\/bkaa147","article-title":"Blood Phosphatidylethanol Concentrations Following Regular Exposure to an Alcohol-Based Mouthwash","volume":"45","author":"Reisfield","year":"2021","journal-title":"J Anal Toxicol"},{"key":"2026021902550842000_79.3.161.135","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/jat\/bkab115","article-title":"Blood Phosphatidylethanol (PEth) Concentrations following Intensive Use of an Alcohol-based Hand Sanitizer","volume":"46","author":"Reisfield","year":"2023","journal-title":"J Anal Toxicol"},{"key":"2026021902550842000_79.3.161.136","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-1600.2009.00185.x"},{"key":"2026021902550842000_79.3.161.137","doi-asserted-by":"publisher","DOI":"10.1111\/acer.14611"},{"key":"2026021902550842000_79.3.161.138","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2147\/HMER.S420732","article-title":"Confounders of Serum Phosphatidylethanol: Role of Red Blood Cell Turnover and Cirrhosis","volume":"15","author":"Bartel","year":"2023","journal-title":"Hepat Med"},{"key":"2026021902550842000_79.3.161.139","first-page":"223","article-title":"Falsely low phosphatidylethanol may be associated with biomarkers of haemolytic disease","volume":"132","author":"\u00c5rving","year":"2023","journal-title":"BCPT"},{"key":"2026021902550842000_79.3.161.140","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1111\/trf.17942","article-title":"Characterization of the alcohol biomarker phosphatidylethanol in donor whole blood and apheresis red blood cells: Implications for transfusion recipients","volume":"64","author":"Kinard","year":"2024","journal-title":"Transfusion"},{"key":"2026021902550842000_79.3.161.141","doi-asserted-by":"crossref","first-page":"110909","DOI":"10.1016\/j.clinbiochem.2025.110909","article-title":"Phosphatidylethanol clearance after packed red blood cell transfusion","volume":"137","author":"Iverson","year":"2025","journal-title":"Clin Biochem"},{"key":"2026021902550842000_79.3.161.142","doi-asserted-by":"publisher","DOI":"10.1097\/01.ALC.0000145687.41646.E5"},{"key":"2026021902550842000_79.3.161.143","doi-asserted-by":"crossref","unstructured":"Aradottir S , Olsson BL . Methodological modifications on quantification of phosphatidylethanol in blood from humans abusing alcohol, using high-performance liquid chromatography and evaporative light scattering detection. BMC Biochem 2005;6. doi:10.1186\/1471-2091-6-18","DOI":"10.1186\/1471-2091-6-18"},{"key":"2026021902550842000_79.3.161.144","unstructured":"Office for health improvement and disparities: estimates of alcohol dependency in adults: summary. 2024. Available: https:\/\/www.gov.uk\/government\/publications\/alcohol-dependence-prevalence-in-england\/estimates-of-alcohol-dependent-adults-in-england-summary [Accessed 5 Mar 2025]."}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jcp-2024-210001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T10:55:33Z","timestamp":1771498533000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jcp-2024-210001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":144,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,2,19]]},"published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1136\/jcp-2024-210001"],"URL":"https:\/\/doi.org\/10.1136\/jcp-2024-210001","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]}}}